Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Communication about the risks and benefits of phase I pediatric oncology trials.

Hazen RA, Zyzanski S, Baker JN, Drotar D, Kodish E. Communication about the risks and benefits of phase I pediatric oncology trials. Contemp Clin Trials. 2015 Mar; 41:139-45.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.